Long-acting risperidone improves negative symptoms in stable psychotic patients

被引：0
|
作者：
Curtis, V. A.
Katsafouros, K.
Moeller, H. J.
Medori, R.
Sacchetti, E.
机构：
[1] Maudsley Hosp & Inst Psychiat, Inst Psychiat, London SE5 8AZ, England
[2] Dromokait State Hosp, Psychotherapeut Ctr, Tarsi Psychiat Clin, Athens, Greece
[3] Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[4] Med Affairs EMEA, Beerse, Belgium
[5] Univ Brescia, Sch Med, Univ Psychiat Unit, Brescia, Italy
[6] Brescia Spedali Civili, Dept Mental Hlth, Brescia, Italy
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
10.1016/j.eurpsy.2007.01.487
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [21] Use of long-acting risperidone in the treatment of bipolar patients
    Savas, Haluk A.
    Yumru, Mehmet
    Ozen, Murat Eren
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (05) : 530 - 531
  • [22] Risperidone long-acting injectable in dual diagnosed patients
    Batlle, E
    Andres, I
    Bastardas, J
    Fernandez, T
    Ferrer, J
    Lozano, L
    Martinez, J
    Menus, R
    Mola, M
    Vazquez, G
    Vazquez, JM
    EUROPEAN PSYCHIATRY, 2005, 20 : S30 - S31
  • [23] Olanzapine-treated patients with psychotic disorders improved after changing to risperidone long-acting injectable
    Chrzanowski, W
    Latif, M
    Masiak, M
    Medori, R
    Gastpar, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S66 - S66
  • [24] COLLABORATIVE STUDY OF COMPLIANCE IN PSYCHOTIC PATIENTS WITH RISPERIDONE LONG-ACTING INJECTION (RLAI) IN THE LAST 5 YEARS
    Molina Ramos, R.
    Arnillas, H.
    Playa, J.
    Sanchez de Muniain, M.
    LLiteras, M.
    Hernandez, B.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [25] Long-acting risperidone injection versus conventional depots in chronic psychotic patients: a 54 months study
    Romero Guillena, S. L.
    Casas Barquero, N.
    Velez Noguera, J. L.
    Fernandez-Villamor Ortiz, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S476 - S476
  • [26] Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine
    Gastpar, M
    Masiak, M
    Latif, MA
    Frazzingaro, S
    Medori, R
    Lombertie, ER
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 32 - 38
  • [27] Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year
    Fleischhacker, WW
    Rabinowitz, J
    Kemmler, G
    Eerdekens, M
    Mehnert, A
    BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 131 - 136
  • [28] The Response of Psychotic Symptoms in a Patient With Resistant Schizophrenia Under Treatment of High-Dose Risperidone Long-Acting Injection
    Hou, Yi-Cheng
    Lai, Chien-Han
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2014, 26 (03) : E16 - E17
  • [29] Long-acting injectable risperidone improves quality of life in schizophrenic patients: a clinical case series
    Castro-Costa, Erico
    de Castro Andrade, Joao Marcos
    Quites, Lucas
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2008, 30 (04) : 402 - 403
  • [30] COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
    Dilla, T.
    O'Donohoe, P.
    Moeller, J.
    Alvarez, M.
    Sacristan, J.
    San, L.
    Happich, M.
    Tockhorn, A.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A292
12345